Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 22 | 28 | 9 | 92 | 111 |
| Cost of Goods | 17 | 19 | 16 | 69 | 86 |
| Gross Profit | 5 | 9 | -7 | 22 | 26 |
| Operating Expenses | 91 | 88 | 72 | 147 | 151 |
| Operating Income | -69 | -60 | -63 | -55 | -40 |
| Other Income | 0 | 0 | -54 | 0 | 0 |
| Pre-tax Income | -69 | -60 | -118 | -55 | -40 |
| Income Tax | -1 | 1 | 33 | N/A | N/A |
| Net Income Continuous | -68 | -62 | -151 | -55 | -40 |
| Net Income | $-68 | $-62 | $-151 | $-55 | $-40 |
| EPS Basic Continuous Ops | -0.11 | -0.10 | -0.42 | -0.10 | -0.07 |
| EPS Diluted Continuous Ops | -0.11 | -0.10 | -0.42 | -0.10 | -0.07 |
| EBITDA(a) | $-59 | $-50 | $-53 | $-45 | $-29 |